Strides Pharma Science Limited (STAR.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3065
First IPO Date
June 26, 2002
| Name | Title | Pay | Year Born |
| Badree Komandur | MD & Group Chief Executive Officer | 58.1M | 1972 |
| Aditya Arun Kumar | Executive Director of Business Development & Director | 16.2M | N/A |
| Arun Kumar Pillai | Founder & Non-Executive Chairperson | 90M | 1961 |
| Venkata Seetharama Raju Pakalapati | Executive Director | 0 | N/A |
| Vikesh Kumar | Group CFO | 0 | 1985 |
| C. K. Sundar | Executive Vice President of Operations | 0 | N/A |
| Kevin Cook | Senior Vice President of Strides Pharma Inc. | 0 | N/A |
| V. S. Ramaraju | Chief Operating Officer | 0 | N/A |
| Umesh Kale | Chief Quality Officer | 0 | N/A |
| Manjula Ramamurthy | Compliance Officer & Company Secretary | 0 | N/A |
| Nandini Matiyani | Executive Vice President of Human Resources | 0 | N/A |
| Sormistha Ghosh | Group General Counsel and Chief Risk & Sustainability Officer | 0 | N/A |
Strides Pharma Science Limited is a pharmaceutical company that focuses on the development, production, and worldwide commercialization of medicinal products. Its extensive global footprint spans Africa, Australia, North America, Europe, Asia, India, and various other international markets. The company's operations are structured into two distinct segments: Pharmaceutical and Biopharmaceutical. It provides a diverse range of generic pharmaceuticals, available in multiple formats including tablets, hard and soft gelatin capsules, sachets, liquids, nasal sprays, powders, solids, ointments, and creams. Furthermore, Strides Pharma Science creates branded generic offerings for treating chronic ailments such as women's health issues, central nervous system disorders, cardiovascular conditions, diabetes, dermatological concerns, and probiotic support, marketed under brands like Renerve, Unibrol, Combiart, Duotab, and Vitafer. For institutional business, the company supplies drugs targeting infectious diseases, including anti-retrovirals, anti-malarials, anti-tuberculosis, and Hepatitis treatments. Incorporated in 1990, the company is headquartered in Bengaluru, India. It was formerly known as Strides Shasun Limited before adopting its current name in July 2018.